Evidence map›Paper›PMID 37234911›Full record

ArticleCurrent infectious disease reports2023

Johanna B Holm, Kayla A Carter, Jacques Ravel, Rebecca M Brotman

Open access · greenAbstract read
In one paragraph

Article in Current infectious disease reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 46 citations in OpenAlex.

  1. Utilizing natural competence to genetically manipulateApplied and environmental microbiology · 2026
    Article
  2. Article
  3. VaginalMicroorganisms · 2026
    Article
  4. Review
  5. Article
  6. Sequencing the genome ofMicrobiology resource announcements · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. mSystems · 2025
    Article
  14. Article
  15. Complete genome sequences of sixMicrobiology resource announcements · 2025
    Article
  16. Article
  17. Practical media formulations for rapid growth ofApplied and environmental microbiology · 2025
    Article
  18. Article
  19. Bacterial vaginosis.Nature reviews. Disease primers · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Johanna B HolmInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-7646-4085
Kayla A CarterInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4836-0932
Jacques RavelInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-0851-2233
Rebecca M BrotmanInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-8762-6214
University of Maryland, Baltimore · US

Funding

The Effects of Sex Hormones on Chlamydia InfectionU19AI158930 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BAVOIL, PATRIK M, GLEGHORN, JASON PAUL · 2021 to 2025
$7.7M
Lubricant Use and the Vaginal MicrobiomeR01AI119012 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROTMAN, REBECCA M. · 2016 to 2020
$3.7M
Longitudinal Study of the Vaginal Microbiome Prior To Incident STIR01AI116799 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROTMAN, REBECCA M. · 2015 to 2019
$3.5M
Methods to Test the Role of Age-related Lifestyle and Vaginal Microenvironment Changes and the Prevention, Treatment, and Progression of Genitourinary Syndrome of MenopauseR01AG069915 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI REBECCA M. BROTMAN, Michelle Denise Shardell · 2021 to 2026
$3.1M
Elucidating causes of vaginal symptoms using a multi-omics approach - Admin. SupplementR01NR015495 · NINR · UNIVERSITY OF MARYLAND BALTIMORE · PI FORNEY, LARRY J, RAVEL, JACQUES · 2016 to 2020
$2.6M
Systems-Level Research in Microbial PathogenesisT32AI162579 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NICHOLAS H CARBONETTI, Julie Dunning Hotopp · 2022 to 2026
$1.7M
Integrating multi-omics data: Modeling biomarkers and mechanisms to reduce bacterial vaginosis recurrenceK01AI163413 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HOLM, JOHANNA B. · 2021 to 2025
$464k
Host-Microbe Interactions and Incident InfectionF32AI136400 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HOLM, JOHANNA B. · 2018 to 2020
$192k
NIAID NIH HHS F32 AI136400NIAID NIH HHS K01 AI163413NIAID NIH HHS R01 AI116799NIAID NIH HHS R01 AI119012NIAID NIH HHS T32 AI162579NIAID NIH HHS U19 AI158930NIA NIH HHS R01 AG069915NINR NIH HHS R01 NR015495
6 · The paper itself

Abstract

Purpose of review: Vaginal lactobacilli are recognized as important drivers of genital health including protection against bacterial vaginosis and sexually transmitted infections. Recent findings: Summary: The worldwide high prevalence of

Indexed as

bacterial vaginosisLactobacillus inersmetagenomesexually transmitted infectionstranscriptomevaginal microbiome

Identifiers

PMID37234911
PMCPMC10209668
OpenAlexW4323359474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.